CLINICAL TRIALS PROFILE FOR INAPSINE
✉ Email this page to a colleague
All Clinical Trials for INAPSINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05244460 ↗ | Droperidol on Prevention of Cannabis Hyperemesis Syndrome | Recruiting | Lake Erie College of Osteopathic Medicine | Phase 3 | 2021-12-02 | The purpose of this study is to assess the efficacy of droperidol as a treatment of cannabinoid hyperemesis syndrome. |
NCT05244460 ↗ | Droperidol on Prevention of Cannabis Hyperemesis Syndrome | Recruiting | Mercy Health Ohio | Phase 3 | 2021-12-02 | The purpose of this study is to assess the efficacy of droperidol as a treatment of cannabinoid hyperemesis syndrome. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for INAPSINE
Condition Name
Clinical Trial Locations for INAPSINE
Trials by Country
Clinical Trial Progress for INAPSINE
Clinical Trial Phase
Clinical Trial Sponsors for INAPSINE
Sponsor Name